Stay updated on Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision number was updated from v3.5.2 to v3.5.3, indicating a minor platform/release change without altering the study record.
    Difference
    0.1%
    Check dated 2026-04-24T06:37:23.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:49:09.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Site revision history shows an addition of v3.5.0 and deletion of v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T08:53:12.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T04:29:36.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is added, replacing earlier revisions. The funding-lapse notice and Revision v3.4.1 have been removed.
    Difference
    0.4%
    Check dated 2026-02-11T17:09:18.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a site-wide notice about possible delays due to funding, and updated the page revision to v3.4.1. The previous revision was v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:48:13.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lanreotide for GI NETs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lanreotide for GI NETs Clinical Trial page.